Table 2.
Cohort | Training cohort | |||||
---|---|---|---|---|---|---|
Variable | Univariate | Multivariate | ||||
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Immune infiltrating score | 6.459 | 4.409–9.462 | < 0.001 | 5.322 | 3.574–7.926 | < 0.001 |
Age | 1.025 | 1.014–1.035 | < 0.001 | 1.024 | 1.014–1.035 | < 0.001 |
Sex | 0.031 | 0.079 | ||||
Female | Reference | Reference | ||||
Male | 1.245 | 1.021–1.518 | 0.031 | 1.196 | 0.979–1.460 | 0.079 |
TNM stage | < 0.001 | < 0.001 | ||||
Stage I | Reference | Reference | ||||
Stage II–III | 2.682 | 2.195–3.278 | < 0.001 | 2.443 | 1.996–2.990 | < 0.001 |
Stage IV | 2.256 | 0.721–7.053 | 0.162 | 1.835 | 0.586–5.740 | 0.297 |
HR hazard ratio, CI confidence interval